
Ipamorelin
5mg · 2ml
SKU: ipamorelin-5mg
Ipamorelin is a selective growth hormone-releasing peptide (GHRP) that stimulates endogenous growth hormone release by binding to the ghrelin receptor in the pituitary gland without significantly increasing cortisol or prolactin. It supports enhanced muscle and connective tissue recovery, improved fat metabolism, lean muscle development, and better sleep quality.
Available Options
Product Specifications
Strength
5mg
Volume / Qty
2ml
Form
Lyophilized Powder
Dosing Guide
Recommended Dose
200-300 mcg
Route
Subcutaneous
Frequency
1-3x daily
Clinician Access Required
Sign in to view clinician pricing & place orders
Ipamorelin is available exclusively to verified clinicians under IRB-approved research protocol PPRN-001-2025.
IRB-Approved Research Protocol
PPRN-001-2025 ·IRCM-2025-467
Approved December 3, 2025 · Principal Investigator: Dr. M. Scott Mortensen, MD, MPAS, MLT
Save up to 80% with the 10,000 Growth Bundle
Ipamorelin is included in this clinic-tier package. Bundle includes higher volume in weight loss, mitochondrial health, longevity, and tissue repair with 1 free Tirz 15mg + 1 free Reta 15mg as a bonus.
Most popular
Also frequently ordered
What other clinicians put in the same cart.
For Clinicians
Clinical Reference
Pharmacology, safety, monitoring, and dosing reference for Ipamorelin. Always individualize based on patient context.
Mechanism of Action
Receptor / Target
Ghrelin receptor (GHS-R1a) agonist; selective GH secretagogue
Half-Life
~2 hours
Onset of Action
15–30 minutes for GH pulse
Metabolism
Renal and hepatic proteolysis
Cautions & Contraindications
Contraindicated In
- Active malignancy
- Hypersensitivity to ipamorelin
Use Caution With
- Sleep apnea
- Insulin resistance and pre-diabetes
- Use lowest effective dose to avoid pituitary desensitization
Suggested Labs to Monitor
IGF-1
Baseline / 6 weeksFasting glucose and HbA1c
Baseline / 12 weeksCortisol AM
Baseline / 12 weeksIpamorelin is selective and should not raise prolactin/cortisol — verify selectivity.
Lab interpretation guidance comes from peer-reviewed literature. Always individualize based on patient context.
Plumb DISCOVER
What Ipamorelin targets
Patient goals, biomarkers, and wearable signals this peptide addresses. Powers the future Plumb AI protocol engine.
Patient Goals
Biomarkers Tracked
Wearable Signals
Essential Protocol Packages
Ipamorelin is part of 1 clinical protocol
Bundle this peptide with synergistic compounds at clinic-tier pricing.
Clinical Synergy
Frequently stacked with Ipamorelin
Peptides commonly combined with Ipamorelin for synergistic clinical outcomes.
Related Products

Tesamorelin 10mg
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that activates pituitary GHRH receptors to increase endogenous growth hormone release and downstream IGF-1 production. It preserves natural feedback mechanisms while supporting enhanced lipolysis, protein synthesis, and metabolic signaling, particularly targeting visceral adipose tissue reduction.
View Details
Hexarelin 5mg
Synthetic growth hormone secretagogue with cardioprotective properties.
View Details
IGF-1 LR3 1mg
Long-acting insulin-like growth factor for muscle growth and recovery.
View Details
GHRP-2 10mg
Growth hormone releasing peptide-2 for GH secretion and appetite stimulation.
View Details





